The next chapter

CEO Communique
Date:  2019-07-04
Author:   Dr. Sean Hall
Medlab Botany Office

First it would be remiss of me not to shout out to the wonderful Staff I employ.

June is normally the “madness” month as companies do all things to finalise the financial year; for us, that was no exception, but factor in opening and relocation to our second Sydney site.

Yes as “Murphy “ had it, in the June madness we opened our second facility, some 2,000 square metres of office and distribution space.

Why you ask?

We simply outgrew our primary site. The nutraceutical expansion is taking off in such a manner that space has moved from critical to super-critical.

For sure, we were on top of one another at our primary site, we worked with several off-site distribution facilities and getting creative with storage space became part of the daily routine– trust me when I say frustrating and challenging at best.

Today Medlab operates out of 2 Sydney facilities:

Laboratory, Research, Regulatory and Clinical have about 800 square metres at McCauley St in Alexandria, and Corporate, Operations, Finance, Logistics and Commercial have about 2,000 square metres at Lord St in Botany.

Add this to our international presence, and we are growing.

Whilst I will not dive into speculative EOFY results – that will follow soon enough; I am very pleased with the performance of the company. As a group we have:

  1. Engaged, and launched into Australian Banner Pharmacies

  2. Engaged larger Multi-Nationals for trade deals

  3. Developed truly innovative products, with patents

  4. Discovered, published and developed several unique drug potential candidates

    • Medlab cannabis-based Medicine (NanoCelleTM CBD:THC – in market, currently under investigation for Cancer pain) – to which (in my opinion) is excelling at all fronts

    • NRGBioticTM (in market, specialised probiotic currently under investigation for Depression treatment) – which (again in my opinion) shaping up to offer a very compelling story.

It has been an incredible year for us; a year that has provided significant opportunities in the near future – thank you to all involved.


Tell us what you think login to share your thoughts.


Dr. Sean Hall, Chief Executive Officer of Medlab
Chief Executive Officer
Dr. Sean Hall

Sean founded Medlab in August 2012; he has over 20 years' experience in nutraceutical sales and development, as well as early drug discovery in Australia, Asia and the US. Sean has led and inspired his teams to author multiple patents, write peer-reviewed articles and deliver lectures at scientific conferences. His passion is leading his researchers into novel areas and strong commercialisation opportunities.

Prior Sean was a founder of FIT-BioCeuticals. Under his management and guidance, BioCeuticals became the most innovative, research-driven, practitioner brand in Australia. For his sale of FIT-BioCeuticals to Blackmores in 2012, Sean was nominated as a finalist in the inaugural Australian Exit CEO of the Year Award. Sean is a Medical Doctor with an MBA in clinical pharmaceutical management and focuses on the research to pioneer innovation and commercialisation. Sean is an active member of Medicines Australia, the European Medical Association, the American Federation for Medical Researcher, The World Medical Association, A4M and Special Operations Medical Association.